Compare MBWM & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBWM | AMPH |
|---|---|---|
| Founded | 1997 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.7M | 971.8M |
| IPO Year | 1997 | 2005 |
| Metric | MBWM | AMPH |
|---|---|---|
| Price | $53.87 | $18.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $55.67 | $28.38 |
| AVG Volume (30 Days) | 121.3K | ★ 614.5K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | ★ 10.95 | N/A |
| EPS | ★ 1.32 | 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $20.28 | $6.90 |
| Revenue Next Year | $4.67 | $4.64 |
| P/E Ratio | ★ $40.25 | $139.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.69 | $16.65 |
| 52 Week High | $55.77 | $31.26 |
| Indicator | MBWM | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.98 | 45.67 |
| Support Level | $50.02 | $18.92 |
| Resistance Level | $54.00 | $19.81 |
| Average True Range (ATR) | 1.46 | 0.76 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 61.10 | 41.78 |
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.